The Evolution of Current Management for Carotid Artery Bifurcation Disease

Tirajeh Zohourian; George Hines

doi:10.1097/CRD.0000000000000497

The Evolution of Current Management for Carotid Artery Bifurcation Disease

Cardiol Rev. 2024 May-Jun;32(3):257-262. doi: 10.1097/CRD.0000000000000497. Epub 2022 Dec 20.

Authors

Tirajeh Zohourian^{1

2}, George Hines^{1

2

3}

Affiliations

¹ From the Department of Surgery, New York University Langone Long Island Hospital, Mineola, NY.
² Department of Surgery, New York University Long Island School of Medicine, Mineola, NY.
³ New York University Langone Vascular Surgery Associates-Mineola, Mineola, NY.

PMID: 36729106
DOI: 10.1097/CRD.0000000000000497

Abstract

Options for treatment of symptomatic carotid bifurcation disease include carotid endarterectomy (CEA) and carotid artery stenting (CAS). While over the years CEA has established itself as the gold standard for carotid artery revascularization, results from recent trials have shown CAS to be safe and effective in selected patients. This review details the evolution of carotid artery bifurcation disease by highlighting key clinical trials.

Publication types

Review

MeSH terms

Carotid Arteries
Carotid Artery Diseases* / surgery
Carotid Stenosis* / surgery
Endarterectomy, Carotid* / methods
Humans
Risk Factors
Stents
Stroke*
Treatment Outcome